| MeSH term | MeSH ID | Detail |
|---|---|---|
| Male Urogenital Diseases | D052801 | 1 associated lipids |
| Trichiasis | D058457 | 1 associated lipids |
| Reproductive Tract Infections | D060737 | 1 associated lipids |
| Corneal Endothelial Cell Loss | D055954 | 1 associated lipids |
| Frontal Sinusitis | D015522 | 1 associated lipids |
| Hyper-IgM Immunodeficiency Syndrome | D053306 | 1 associated lipids |
| Paratyphoid Fever | D010284 | 1 associated lipids |
| Asymptomatic Infections | D058345 | 1 associated lipids |
| T-Lymphocytopenia, Idiopathic CD4-Positive | D018344 | 1 associated lipids |
| Ectodermal Dysplasia | D004476 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cheng B | Advances in prevention and treatment of MAC. | 1995 | PI Perspect | pmid:11363104 |
| Hunter RP et al. | Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. | 1995 | J. Vet. Pharmacol. Ther. | pmid:7752305 |
| Ives DV et al. | Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. | 1995 | AIDS | pmid:7755914 |
| Onyeji CO et al. | Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. | 1995 | J. Infect. Dis. | pmid:7658075 |
| Debets-Ossenkopp YJ et al. | Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents. | 1995 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:7649202 |
| Adal KA et al. | Photo quiz. Bacillary angiomatosis. | 1995 | Clin. Infect. Dis. | pmid:7727641 |
| Bermudez LE et al. | Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice. | 1995 | J. Antimicrob. Chemother. | pmid:8591938 |
| Domingo S et al. | Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. | 1995 | J. Antimicrob. Chemother. | pmid:8591939 |
| Nash KA and Inderlied CB | Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. | 1995 | Antimicrob. Agents Chemother. | pmid:8592991 |
| Bohte R et al. | Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. | 1995 | Antimicrob. Agents Chemother. | pmid:8593024 |
| Tribble D et al. | Efficacy of azithromycin for typhoid fever. | 1995 | Clin. Infect. Dis. | pmid:8645805 |
| Strickman D et al. | In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. | 1995 | Antimicrob. Agents Chemother. | pmid:8585717 |
| Kuzman I et al. | Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. | 1995 | Scand. J. Infect. Dis. | pmid:8588143 |
| Silvestri M et al. | Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes. | 1995 | J. Antimicrob. Chemother. | pmid:8821593 |
| Patton DL et al. | The activity of azithromycin on the infectivity of Chlamydia trachomatis in human amniotic cells. | 1995 | J. Antimicrob. Chemother. | pmid:8821594 |
| Martin DH et al. | Comparison of azithromycin and ceftriaxone for the treatment of chancroid. | 1995 | Clin. Infect. Dis. | pmid:8562752 |
| Kieserman SP et al. | Streptococcal pharyngitis: alternative treatments. | 1995 | Ear Nose Throat J | pmid:8536567 |
| van Rijsoort-Vos JH et al. | In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae. | 1995 | J. Antimicrob. Chemother. | pmid:8537268 |
| Carbon C | [Azithromycin: from macrolides to azalides]. | 1995 | Pathol. Biol. | pmid:8539067 |
| [Special issue devoted to azithromycin]. | 1995 | Pathol. Biol. | pmid:8539068 | |
| Bergogne-Bérézin E | [Azithromycin: tissue pharmacology]. | 1995 | Pathol. Biol. | pmid:8539071 |
| Clancy J et al. | Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. | 1995 | J. Antibiot. | pmid:8557568 |
| Amsden GW | Macrolides versus azalides: a drug interaction update. | 1995 | Ann Pharmacother | pmid:8547740 |
| Beckers CJ et al. | Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. | 1995 | J. Clin. Invest. | pmid:7814637 |
| Friis HM | [Azithromycin--an exciting new antibiotic]. | 1995 | Ugeskr. Laeg. | pmid:7831724 |
| Dessau RB | [Azithromycin]. | 1995 | Ugeskr. Laeg. | pmid:7831733 |
| Sasaki J et al. | [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection]. | 1995 | Jpn J Antibiot | pmid:7474331 |
| Uchino U et al. | [Effects of azithromycin on fecal flora of healthy adult volunteers]. | 1995 | Jpn J Antibiot | pmid:7474332 |
| Toscano MA et al. | [Efficacy and tolerance of azithromycin in respiratory tract infections in children]. | 1995 | Minerva Pediatr. | pmid:7476752 |
| Scheen AJ | [Pharma-clinics. Drug of the month. Azithromycin (Zitromax)]. | 1995 | Rev Med Liege | pmid:7481274 |
| Nahata MC et al. | Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. | 1995 | Antimicrob. Agents Chemother. | pmid:7486938 |
| Tomazic J et al. | Ex vivo effect of azithromycin in human leukocyte bactericidal functions. | 1995 | Antimicrob. Agents Chemother. | pmid:7486947 |
| al-Assi MT et al. | Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. | 1995 | Am. J. Gastroenterol. | pmid:7872278 |
| Andersen SL et al. | Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. | 1995 | Am. J. Trop. Med. Hyg. | pmid:7872444 |
| Zuckerman JM and Kaye KM | The newer macrolides. Azithromycin and clarithromycin. | 1995 | Infect. Dis. Clin. North Am. | pmid:7490441 |
| Schlossberg D | Azithromycin and clarithromycin. | 1995 | Med. Clin. North Am. | pmid:7791424 |
| Weber JT and Johnson RE | New treatments for Chlamydia trachomatis genital infection. | 1995 | Clin. Infect. Dis. | pmid:7795110 |
| Kobayashi H et al. | [Study on azithromycin in treatment of diffuse panbronchiolitis]. | 1995 | Kansenshogaku Zasshi | pmid:7616016 |
| Ljutić D and Rumboldt Z | Possible interaction between azithromycin and cyclosporin: a case report. | 1995 | Nephron | pmid:7617103 |
| Anderson SL et al. | Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. | 1995 | Ann. Intern. Med. | pmid:7574195 |
| Backman JT et al. | Azithromycin does not increase plasma concentrations of oral midazolam. | 1995 | Int J Clin Pharmacol Ther | pmid:7582388 |
| Harris S et al. | Azithromycin and terfenadine: lack of drug interaction. | 1995 | Clin. Pharmacol. Ther. | pmid:7554704 |
| Bokemeyer B | [Combined therapy with azithromycin and omeprazole for the eradication of Helicobacter pylori]. | 1995 | Dtsch. Med. Wochenschr. | pmid:7555645 |
| Péc J et al. | [Treatment of chlamydia infections and a brief review of the problems]. | 1995 | Bratisl Lek Listy | pmid:7633932 |
| Rizzato G et al. | Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. | 1995 | Eur. Respir. J. | pmid:7789484 |
| Pascual A et al. | Factors affecting the intracellular accumulation and activity of azithromycin. | 1995 | J. Antimicrob. Chemother. | pmid:7768786 |
| Beghi G et al. | Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. | 1995 | J Chemother | pmid:7666122 |
| Amland PF et al. | A prospective, double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infections in plastic surgery. | 1995 | Plast. Reconstr. Surg. | pmid:7480237 |
| [New ways of antibiotic therapy]. | 1995 | Internist (Berl) | pmid:9431354 | |
| Domingo S et al. | Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis. | 1995 | J Chemother | pmid:8904096 |